Table 2.
Stimulation and laboratory results of the study subjects
| Variable | Dual trigger (n=40) | hCG trigger (n=36) | p-value |
|---|---|---|---|
| Gonadotropin combination | 0.628 | ||
| rFSH only (%) | 50.0 (20/40) | 55.6 (20/36) | |
| rFSH+hMG (%) | 50.0 (20/40) | 44.4 (16/36) | |
| Duration of stimulation (day) | 7.3±2.1 | 7.7±2.0 | 0.440 |
| Total dose of FSH used (IU) | 1,658±642 | 1,874±829 | 0.207 |
| FSH dose/oocyte | 457±389 | 536±490 | 0.439 |
| FSH dose/mature oocyte | 634±480 | 982±748 | 0.030a) |
| Estradiol on triggering day (pg/mL) | 1,007±597 | 981±548 | 0.875 |
| Number of total oocytes retrieved | 5.3±3.5 | 5.0±2.7 | 0.655 |
| Number of mature oocytes retrieved | 3.7±2.7 | 2.3±1.7 | 0.010 |
| Degenerative oocyte rate | 0.5 (1/213) | 1.7 (3/180) | 0.336 |
| Oocyte maturation rate | 68.5 (146/213) | 45.6 (82/180) | <0.001 |
Values are presented as percent (number) or mean±standard deviation.
hCG, human chorionic gonadotropin; rFSH, recombinant follicle-stimulating hormone; hMG, human menopausal gonadotrophin; FSH, follicle-stimulating hormone.